CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Jun 29 - Jul 5, 2026

This Week's Biotech Catalysts

All FDA decisions, clinical trial readouts, and key events happening this week.

52

Total Events

5

PDUFA Dates

51

Trial Readouts

Monday

June 298
Jun '26
MRKPhase 2

Olaparib Phase 2 Est. Readout

Olaparib
Jun 2026~
CT.gov
00%
Jun '26
TVRDPhase 2

TTI-101 Phase 2 Est. Readout

TTI-101
Jun 2026~
CT.gov
00%
Past
days
MANEEarnings

MANE Earnings Report

Jun 29
Source
Past
days
RAREPDUFA
Phase 3?Unknown

FDA PDUFA Date UX111 (standard)

UX111
Jun 29
SEC
Past
days
HELPEarnings

HELP Earnings Report

Jun 29
Source
Past
days
EIKNEarnings

EIKN Earnings Report

Jun 29
Source
Past
days
AKTSEarnings

AKTS Earnings Report

Jun 29
Source
Jun '26
SNYPhase 3

Amlitelimab Phase 3 Est. Readout

Amlitelimab
Jun 2026~
CT.gov
00%

Tuesday

June 3055
Past
days
INCYPhase 3

Ruxolitinib Phase 3 Est. Readout

Ruxolitinib
Jun 30
CT.gov
00%
Past
days
CELCPhase 3
✓Positive

Gedatolisib Phase 3 Results Expected

Gedatolisib
Jun 30
CT.gov
Jun '26
MRKPhase 3
✓Positive

Rescue Medication Phase 3 Est. Readout

Rescue medication
Jun 2026~
CT.gov
Past
days
AVXLEarnings

AVXL Earnings Report

Jun 30
Source
Past
days
TTRXEarnings

TTRX Earnings Report

Jun 30
Source
Past
days
UCFIEarnings

UCFI Earnings Report

Jun 30
Source
Past
days
ANABPDUFA
NDA?Unknown

FDA PDUFA Date

Jun 30
SEC
Past
days
AMGNPhase 3
✓Positive

Pembrolizumab Phase 3 Results Expected

Pembrolizumab
Jun 30
CT.gov
Past
days
GRCEPDUFA
NDA?Unknown

FDA PDUFA Date GRCE-175 (standard)

GRCE-175
Jun 30
SEC
Jun '26
NVSEFPhase 3
✓Positive

TQJ230 Phase 3 Est. Readout

TQJ230
Jun 2026~
CT.gov
Past
days
PFEPhase 3
✓Positive

carboplatin Phase 3 Results Expected

Carboplatin
Jun 30
CT.gov
Past
days
PFEPhase 3
✓Positive

cisplatin Phase 3 Results Expected

cisplatin
Jun 30
CT.gov
Jun '26
RHHBYPhase 3
✓Positive

Atezolizumab Phase 3 Est. Readout

Lenvatinib
Jun 2026~
CT.gov
Jun '26
TLXPhase 3

89Zr-TLX250 PET/CT Phase 3 Est. Readout

89Zr-TLX250 PET/CT
Jun 2026~
CT.gov
00%
Jun '26
OLMAPhase 3

Palazestrant Phase 3 Est. Readout

Palazestrant
Jun 2026~
CT.gov
00%
Jun '26
ZBIOPhase 3
✓Positive

Obexelimab Phase 3 Est. Readout

Obexelimab
Jun 2026~
CT.gov
Past
days
VYGRPhase 1

Phase 1 Results - VY1706

Jun 30STALE
Source
00%
Past
days
COLLM&A
✓Positive

Acquisition - AZSTARYS

Jun 30
Source
Jun '26
RHHBYPhase 2

Entrectinib Phase 2 Est. Readout

Entrectinib
Jun 2026~
CT.gov
00%
Jun '26
PFEPhase 3
✗Negative

gemcitabine Phase 3 Est. Readout

Gemcitabine
Jun 2026~
CT.gov
Jun '26
CELCPhase 3
✓Positive

Palbociclib Phase 3 Est. Readout

Palbociclib
Jun 2026~
CT.gov
Jun '26
MAIAPhase 2

6-Thio-2'-Deoxyguanosine Phase 2 Est. Readout

6-Thio-2'-Deoxyguanosine
Jun 2026~
CT.gov
00%
Jun '26
MRTXPhase 2

MRTX849 Phase 2 Est. Readout

MRTX849
Jun 2026~
CT.gov
00%
Jun '26
JNJPhase 3
✓Positive

JNJ-90301900 (NBTXR3) Phase 3 Est. Readout

JNJ-90301900 (NBTXR3)
Jun 2026~
CT.gov
Jun '26
MDNAFPhase 2

MDNA11 Phase 2 Est. Readout

MDNA11
Jun 2026~
CT.gov
00%
Jun '26
SGIOYPhase 2

Redasemtide Phase 2 Est. Readout

Redasemtide
Jun 2026~
CT.gov
00%
Jun '26
ENGNPhase 2
~Mixed

EG-70 (phase 1) Phase 2 Est. Readout

EG-70 (phase 1)
Jun 2026~
CT.gov
Jun '26
MRNAPhase 2

mRNA-1468 Phase 2 Est. Readout

mRNA-1468
Jun 2026~
CT.gov
00%
Past
days
EYPTPhase 3

EYP-1901 Phase 3 Est. Readout

EYP-1901
Jun 30
CT.gov
00%
Jun '26
ALPMYPhase 3

Tamoxifen Phase 3 Est. Readout

Tamoxifen
Jun 2026~
CT.gov
00%
Past
days
KYTXNDA Filing

NDA Filing

Jun 30STALE
Source
00%
Past
days
AURAPhase 3

Phase 3 Results - bel-sar

Bel-sar
Jun 30STALE
Source
00%
Past
days
RLMDPhase 3

Phase 3 Results - RESCUE

Jun 30STALE
Source
00%
Past
days
CHRSData Readout

Data Readout

Jun 30STALE
Source
00%
Past
days
AVAHM&A

Acquisition

Jun 30STALE
Source
Past
days
KPTIPhase 3

Phase 3 — XPOVIO

Jun 30STALE
Source
00%
Past
days
EDSAPhase 2

Phase 2 Results

Jun 30STALE
Source
00%
Past
days
NRSNEarnings

NRSN Earnings Report

Jun 30
Source
Jun '26
AZNCFPhase 2

Oleclumab Phase 2 Est. Readout

Oleclumab
Jun 2026~
CT.gov
00%
Past
days
DYNNDA Filing

NDA Filing - z-rostudirsen

Jun 30STALE
Source
00%
Past
days
GENBPhase 3

Phase 3 — GB-0895

Jun 30STALE
Source
00%
Jun '26
IVBXFPhase 2

IBI3014 Phase 2 Est. Readout

IBI3014
Jun 2026~
CT.gov
00%
Jun '26
UCBJYPhase 2

doxecitine and doxribtimine Phase 2 Est. Readout

doxecitine and doxribtimine
Jun 2026~
CT.gov
00%
Past
days
INCYPhase 3
✓Positive

Phase 3 — 989

Jun 30
Source
Past
days
AMGNPhase 3
✗Negative

Sotorasib Phase 3 Results Expected

Sotorasib
Jun 30
CT.gov
Jun '26
BGNEPhase 3
✓Positive

Pamiparib capsule Phase 3 Est. Readout

Pamiparib capsule
Jun 2026~
CT.gov
Jun '26
MRKPhase 2
✗Negative

Rescue Medication Phase 2 Est. Readout

Rescue medication
Jun 2026~
CT.gov
Jun '26
RHHBYPhase 3
✓Positive

Tociluzumab Phase 3 Est. Readout

Tociluzumab
Jun 2026~
CT.gov
Jun '26
SOPHPhase 3

Moxifloxacin / Dexamethasone Ophthalmic Solution Phase 3 Est. Readout

Moxifloxacin / Dexamethasone Ophthalmic Solution
Jun 2026~
CT.gov
00%
Jun '26
AZNPhase 3
✓Positive

Durvalumab Phase 3 Est. Readout

Durvalumab
Jun 2026~
CT.gov
Jun '26
AZNPhase 3
✓Positive

Oleclumab Phase 3 Results Expected

Oleclumab
Jun 2026~
CT.gov
Jun '26
NVSPhase 2

68Ga-FAP-2286 Phase 2 Est. Readout

68Ga-FAP-2286
Jun 2026~
CT.gov
00%
Past
days
ADCTData Readout
✗Negative

Data Readout - ZYNLONTA

Jun 30
Source
Past
days
NVSPhase 3
✓Positive

TQJ230 Phase 3 Results Expected

TQJ230
Jun 30
CT.gov
Jun '26
CLLSPhase 2

UCART22 Phase 2 Est. Readout

UCART22
Jun 2026~
CT.gov
00%

Wednesday

July 19
Past
days
LLYRegulatory
✓Positive

Regulatory — Foundayo

Jul 1
Source
Past
days
HROWRegulatory

Regulatory — IOPIDINE® 1%

Jul 1STALE
Source
00%
Past
days
NSRXEarnings

NSRX Earnings Report

Jul 1
Source
Past
days
CAPRPDUFA
NDA?Unknown

FDA PDUFA Date

Jul 1
SEC
Past
days
SCNIEarnings

SCNI Earnings Report

Jul 1
Source
Past
days
ARDXRegulatory
✗Negative

Regulatory Decision - Xphozah

Jul 1
Source
Past
days
SNYEarnings

SNY Earnings Report

Jul 1
Source
Jul '26
GSKPhase 3
✓Positive

Investigational varicella vaccine Phase 3 Est. Readout

Investigational varicella vaccine
Jul 2026~
CT.gov
Jul '26
AZNCFPhase 2

Durvalumab Phase 2 Est. Readout

Durvalumab
Jul 2026~
CT.gov
00%

Thursday

July 27
Jul '26
AMGNPhase 2

AMG 193 Phase 2 Est. Readout

AMG 193
Jul 2026~
CT.gov
00%
Past
days
IONSRegulatory
✓Positive

Regulatory Decision - Tryngolza

Jul 2
Source
Past
days
HCMEarnings

HCM Earnings Report

Jul 2
Source
Past
days
NBPEarnings

NBP Earnings Report

Jul 2
Source
Past
days
REPLEarnings

REPL Earnings Report

Jul 2
Source
Past
days
TLXEarnings

TLX Earnings Report

Jul 2
Source
Past
days
VRDNPDUFA
Phase 3✓Positive

FDA PDUFA Date VRDN-001 (standard)

VRDN-003
Jul 2
SEC

FridayToday

July 35
Today
BDRXEarnings

BDRX Earnings Report

Jul 3
Source
Today
MODDEarnings

MODD Earnings Report

Jul 3
Source
Today
ENLVEarnings

ENLV Earnings Report

Jul 3
Source
Jul '26
CELG-RIPhase 2

BMS-986435 Phase 2 Est. Readout

BMS-986435
Jul 2026~
CT.gov
00%
Jul '26
INCYPhase 2
✗Negative

INCA034176 Phase 2 Results Expected

INCA034176
Jul 2026~
CT.gov

Saturday

July 4

No events scheduled

Sunday

July 5

No events scheduled

Get Weekly Catalyst Alerts

Receive a summary of upcoming biotech catalysts every Monday morning.

Why Track Weekly Biotech Catalysts?

Biotech stocks are driven by binary events - FDA decisions, clinical trial results, and regulatory milestones. Knowing which catalysts are coming this week helps investors prepare for potential volatility and trading opportunities.

Key Events to Watch

  • PDUFA Dates: FDA target action dates for drug approvals
  • Clinical Trials: Phase 1, 2, and 3 data readouts
  • AdCom Meetings: FDA Advisory Committee votes
  • Conferences: Medical conference presentations

Stay Informed

This page updates automatically as new events are added or outcomes are announced. Bookmark it or sign up for our weekly email digest to never miss an important catalyst.